Sputnik Light, the single-dose COVID vaccine, gets DCGI nod for phase 3 trials in India

The nod comes after a recent study published in the medical journal The Lancet said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against COVID-19, significantly higher than most two-shot vaccines.